Skip to content
Latest news
CinFina Pharma Presents Positive Phase 1 Study Results in Poster Session for CIN-109 and in Late-Breaking Poster for CIN-110, Demonstrating the Potential of Next-Generation Mechanisms at ObesityWeek® 2024
Home
About
Portfolio
Pipeline
News
Contact
Home
About
Portfolio
Pipeline
News
Contact
Our portfolio companies have the potential for transformational change in the way a disease area is treated and significantly improves the patient quality of life.
LEARN MORE
LEARN MORE
LEARN MORE
INVESTOR INQUIRIES
Send Message
CAREER INQUIRIES
Send Message
GENERAL INQUIRIES
Send Message